HKU Study: ‘Exercise Sensor’ Protein Key to Strong Bones & New Osteoporosis Treatments
Researchers have identified a key biological process explaining how physical activity strengthens bones, potentially opening doors to new treatments for osteoporosis and bone loss. This discovery focuses on individuals for whom exercise is not a viable option, offering a new avenue for maintaining bone health.
Understanding the Impact of Bone Loss
Why Bone Loss Becomes More Severe With Age
Osteoporosis and age-related bone loss are widespread health concerns, affecting millions globally. According to the World Health Organization, approximately one in three women and one in five men over 50 will experience fractures due to weakened bones. In Hong Kong, these conditions impact 45% of women and 13% of men aged 65 and older, leading to pain, reduced mobility, and strain on healthcare systems.
As people age, bones naturally lose density, becoming more porous. Within the bone marrow, mesenchymal stem cells play a crucial role, capable of developing into bone tissue or fat cells. These cells respond to physical forces, but aging shifts this balance, causing more cells to become fat, weakening the bone.
The Role of Piezo1
The research team identified a protein called Piezo1, located on the surface of mesenchymal stem cells in bone marrow, that functions as a mechanical sensor. This protein detects physical forces generated during movement and exercise. Experiments using mouse models and human stem cells revealed that when Piezo1 is activated by physical activity, it limits fat buildup and promotes new bone formation.
Conversely, when Piezo1 is absent, stem cells are more likely to become fat cells, accelerating bone loss. The lack of Piezo1 also triggers the release of inflammatory signals – Ccl2 and lipocalin-2 – which further encourage fat production and hinder bone growth. Blocking these signals showed promise in restoring healthier bone conditions.
Mimicking Exercise at a Molecular Level
A New Approach to Treatment
“We have essentially decoded how the body converts movement into stronger bones,” stated Professor Xu Aimin, who led the study. “We have identified the molecular exercise sensor, Piezo1, and the signalling pathways it controls. This gives us a clear target for intervention.”
Researchers envision a future where medications can activate the Piezo1 pathway, effectively “tricking” the body into believing it is exercising, even without actual movement. This could be particularly beneficial for older adults, bedridden patients, and individuals with chronic illnesses who struggle with physical activity.
Dr. Wang Baile, a co-leader of the study, emphasized the potential for developing “exercise mimetics” – drugs that chemically activate the Piezo1 pathway to maintain bone mass and support independence. Professor Eric Honoré added that this strategy extends beyond traditional physical therapy, potentially slowing bone loss in vulnerable populations and reducing fracture risk.
What’s Next?
The research team is now focused on translating these findings into clinical applications, with the goal of developing new therapies to preserve bone strength and improve the quality of life for aging individuals and those confined to bed. A possible next step involves further research into the specific mechanisms of Piezo1 activation and the development of compounds that can effectively mimic its effects.
Frequently Asked Questions
What is Piezo1?
Piezo1 is a protein located on the surface of mesenchymal stem cells in bone marrow that functions as a mechanical sensor, detecting physical forces generated during movement and exercise.
What happens when Piezo1 is not functioning properly?
When Piezo1 is absent, stem cells are more likely to become fat cells, accelerating bone loss. It also triggers the release of inflammatory signals that further promote fat production and interfere with bone growth.
Who could benefit from this research?
Older adults, bedridden patients, and individuals with chronic illnesses who cannot exercise due to frailty, injury, or illness could potentially benefit from therapies developed based on this research.
As research progresses, will we be able to maintain bone health without relying solely on physical activity?